MJT & Associates Financial Advisory Group, Inc.

Position in EXEL — Exelixis, Inc.

CIK 2065777 MONTEVICEO, MN

Position in EXEL

as of Jun 30, 2026 · filed Jul 6, 2026 Compact

Position Value

$544

New position

Shares Held

10

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#47

of 47 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

MJT & Associates Financial Advisory Group, Inc. holds $11,525 across 6 Biotechnology names. EXEL ranks #5 (4.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	44	$4,987
2	HALO	Halozyme Therapeutics, Inc.	41	$3,209
3	SRPT	Sarepta Therapeutics, Inc.	69	$1,239
4	IONS	Ionis Pharmaceuticals Inc	15	$1,189
5	EXEL	Exelixis, Inc. This page	10	$544
6	INO	Inovio Pharmaceuticals, Inc.	325	$357

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$544	10	—	Shares	Sole	2026-07-06
No filing history on record for this holder in this stock.